Launches Campaign Track, that would provide real-time data, accurate and timely information and market specific analysis for Indian pharma companies. Online healthcare service provider, Medlife has joined hands with AIOCD AWACS, a pharmaceutical market research organisation to introduce Campaign Track — a unique product that would provide real-time data, accurate and timely information and market specific analysis for pharma companies in India. The product will be used by pharma companies to gather a comprehensive market linked data and help brand managers understand and analyse the healthcare ecosystem; thereby improve their sales and marketing efficiency. Being one of the largest online pharmacies and healthcare service provider in India, we not only wish to extend our offerings to our consumers and corporates but also make a wider impact by providing market related real-time data to pharmaceutical companies in the country. With Campaign Track, we aim to improve accuracy in information and reduce their turnaround time.
|Published (Last):||7 July 2007|
|PDF File Size:||3.90 Mb|
|ePub File Size:||10.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
Board members of Abbott, led by its chairman Miles D White, are flying down to Mumbai to hold the company's first global meeting in India. Domestic companies grew at a modest pace of 14 per cent as against The combined market share of Sun Pharma 5.
The proposed new entity would unseat Abbott from the top position, which holds current market share of 6. The domestic pharma industry is now witnessing a big slowdown with October becoming the third consecutive month to record sluggish growth.
The economic slowdown has hit the Rs 72, crore domestic pharma business, usually considered recession-proof. Part of domestic drug market brought under price control is pegged at around Rs cr; it is further estimated to shrink by 39 per cent. In a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation in the domestic pharma retail market.
The Indian pharma industry, while being on a roll due to the higher export realisations due to the weaker rupee, has suffered badly in the domestic market. The process of disinvestment of these brands has also been expedited by the two cos to fast-track the acquisition of Ranbaxy by Sun by at least months. All rights reserved. For reprint rights: Times Syndication Service. Panache Bartending to go obsolete in post-Covid world? Robots replace humans, will serve cocktails, carve ice for whisky.
Brand Solutions. TomorrowMakers Let's get smarter about money. ET NOW. ET Portfolio. Abbott Co's board members, chairman to hold first global board meeting in India Board members of Abbott, led by its chairman Miles D White, are flying down to Mumbai to hold the company's first global meeting in India.
Domestic pharma retail market tops Rs 90k crore The robust growth in July was attributed to nine therapies having outgrown the pharma market, All News Videos Photos. How does the Sun Pharma-Ranbaxy deal change the game for the other players in the Indian pharma market? Sun Pharma-Ranbaxy combine creates a new market leader in Indian market 07 Apr, , AM IST The proposed new entity would unseat Abbott from the top position, which holds current market share of 6.
Data shows slowdown in the domestic pharma market 14 Jan, , AM IST December has been the month with one of the lowest growth rates in a long period of time. Slowdown grips domestic pharma market, records sluggish growth for October 29 Nov, , AM IST The domestic pharma industry is now witnessing a big slowdown with October becoming the third consecutive month to record sluggish growth.
Slowdown hits domestic pharma, market shrinks 1. Anti-diabetic drug tops India's pharma sales 18 Jun, , AM IST In a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation in the domestic pharma retail market.
Pharma industry hit by worst slowdown in the domestic market for the month of August 13 Sep, , AM IST The Indian pharma industry, while being on a roll due to the higher export realisations due to the weaker rupee, has suffered badly in the domestic market. Popular Categories Markets Live! Follow us on. Download et app.
Become a member.
This network will churn out a series of information products at different geographic levels, and also service the supply chain and internal sales compilation of several companies. Currently this is at manual data entry mode which will be shifted for the first time to electronic mode. Pharmaceutical Market Research is at a very nascent stage in India. Compared to developed countries, there is a huge gap in the product offering, and the quality of existing offerings is also mediocre.
The ministry has forwarded a list of 55 drugs for ICU management of novel coronavirus patients and a list of another 96 drugs for general availability and treatment of various co-morbid conditions. The list was prepared following a detailed exercise undertaken by the Director General Health Services. Final bids are like Pharmacists in the country have decided to ration the sale of medicines to customers in a bid to curb panic buying and stave off a shortage in supplies. With units still limping back to normalcy across the country and inventory levels running low, there could be shortages ahead of certain essential medicines and devices, companies say. Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal valued at more than Rs. Strides Pharma is likely to resume drug sale, following the report.
AIOCD Pharmasofttech AWACS has launched ’PharmaTrac’